Lv1
60 积分 2025-07-09 加入
Phase 2a Study of Baxdrostat in Primary Aldosteronism
10个月前
已完结
Baxdrostat: A Novel Aldosterone Synthase Inhibitor for Treatment Resistant Hypertension
1年前
已完结
Mineralocorticoid receptor antagonists and aldosterone synthase inhibitors: agent comparison with implications for clinical practice and trial design
1年前
已完结
皖公网安备34019202002308
